Pim-1 mediated signaling during the process of cardiac remodeling following myocardial infarction in ovine hearts

Journal of Molecular and Cellular Cardiology

Volumn 63, Issue , 2013, Pages 89-97

  Gao, Yang ^a,b   Li, Tieluo ^a   Wu, Changfu ^a   Bittle, Gregory J ^a   Chen, Shengxi ^b   Wu, Zhongjun J ^a   Griffith, Bartley P ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

Apoptosis; Cardioprotection; Myocardial infarction; Pim 1; Remodeling

Indexed keywords

COMPLEMENTARY DNA; PROTEIN BAD; PROTEIN BCL 2; PROTEIN BCL XL; PROTEIN KINASE B; PROTEIN KINASE PIM 1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CONTROLLED STUDY; DNA SEQUENCE; ENZYME ACTIVITY; GENE EXPRESSION; HEART; HEART INFARCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE ENDDIASTOLIC VOLUME; HEART LEFT VENTRICLE ENDSYSTOLIC VOLUME; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE CELL; HEART PROTECTION; MALE; MEASUREMENT; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; SONOMICROMETER; UPREGULATION; WALL MOTION ABNORMALITY;

ANIMALIA; OVIS;

APOPTOSIS; CARDIOPROTECTION; MYOCARDIAL INFARCTION; PIM-1; REMODELING;

AMINO ACID SEQUENCE; ANIMALS; APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; BASE SEQUENCE; CELL SURVIVAL; GENE EXPRESSION REGULATION; MALE; MOLECULAR SEQUENCE DATA; MYOCARDIAL INFARCTION; PROTO-ONCOGENE PROTEINS C-PIM-1; SEQUENCE ALIGNMENT; SHEEP; SIGNAL TRANSDUCTION; VENTRICULAR REMODELING;

EID: 84881520697     PISSN: 00222828     EISSN: 10958584     Source Type: Journal    
DOI: 10.1016/j.yjmcc.2013.07.012     Document Type: Article

References (37)

1. Jugdutt B.I. Ventricular remodeling after infarction and the extracellular collagen matrix: when is enough enough?. Circulation 2003, 108:1395-1403.
2. Pfeffer M.A., Braunwald E. Ventricular remodeling after myocardial infarction. Experimental observations and clinical implications. Circulation 1990, 81:1161-1172.
3. Muraski J.A., Rota M., Misao Y., Fransioli J., Cottage C., Gude N., et al. Pim-1 regulates cardiomyocyte survival downstream of Akt. Nat Med 2007, 13:1467-1475.
4. Bachmann M., Moroy T. The serine/threonine kinase Pim-1. Int J Biochem Cell Biol 2005, 37:726-730.
5. Saris C.J., Domen J., Berns A. The pim-1 oncogene encodes two related protein-serine/threonine kinases by alternative initiation at AUG and CUG. EMBO J 1991, 10:655-664.
6. Xie Y., Xu K., Dai B., Guo Z., Jiang T., Chen H., et al. The 44kDa Pim-1 kinase directly interacts with tyrosine kinase Etk/BMX and protects human prostate cancer cells from apoptosis induced by chemotherapeutic drugs. Oncogene 2006, 25:70-78.
7. Aho T.L., Sandholm J., Peltola K.J., Mankonen H.P., Lilly M., Koskinen P.J. Pim-1 kinase promotes inactivation of the pro-apoptotic Bad protein by phosphorylating it on the Ser112 gatekeeper site. FEBS Lett 2004, 571:43-49.
8. Macdonald A., Campbell D.G., Toth R., McLauchlan H., Hastie C.J., Arthur J.S. Pim kinases phosphorylate multiple sites on Bad and promote 14-3-3 binding and dissociation from Bcl-XL. BMC Cell Biol 2006, 7:1.
9. Poolman R.A., Gilchrist R., Brooks G. Cell cycle profiles and expressions of p21CIP1 AND P27KIP1 during myocyte development. Int J Cardiol 1998, 67:133-142.
10. -/- mice: novel mechanistic insights from in utero ultrasound biomicroscopy. Circ Res 2004, 95:92-99.
11. Lilly M., Sandholm J., Cooper J.J., Koskinen P.J., Kraft A. The PIM-1 serine kinase prolongs survival and inhibits apoptosis-related mitochondrial dysfunction in part through a bcl-2-dependent pathway. Oncogene 1999, 18:4022-4031.
12. Borillo G.A., Mason M., Quijada P., Volkers M., Cottage C., McGregor M., et al. Pim-1 kinase protects mitochondrial integrity in cardiomyocytes. Circ Res 2010, 106:1265-1274.
13. Muraski J.A., Fischer K.M., Wu W., Cottage C.T., Quijada P., Mason M., et al. Pim-1 kinase antagonizes aspects of myocardial hypertrophy and compensation to pathological pressure overload. Proc Natl Acad Sci U S A 2008, 105:13889-13894.
14. Mohsin S., Khan M., Toko H., Bailey B., Cottage C.T., Wallach K., et al. Human cardiac progenitor cells engineered with Pim-I kinase enhance myocardial repair. J Am Coll Cardiol 2012, 60:1278-1287.
15. Quijada P., Toko H., Fischer K.M., Bailey B., Reilly P., Hunt K.D., et al. Preservation of myocardial structure is enhanced by pim-1 engineering of bone marrow cells. Circ Res 2012, 111:77-86.
16. Yankey G.K., Li T., Kilic A., Cheng G., Satpute A., Savai K., et al. Regional remodeling strain and its association with myocardial apoptosis after myocardial infarction in an ovine model. J Thorac Cardiovasc Surg 2008, 135(991-8):8e1-8e2.
17. Lyseggen E., Skulstad H., Helle-Valle T., Vartdal T., Urheim S., Rabben S.I., et al. Myocardial strain analysis in acute coronary occlusion: a tool to assess myocardial viability and reperfusion. Circulation 2005, 112:3901-3910.
18. Perk G., Tunick P.A., Kronzon I. Non-Doppler two-dimensional strain imaging by echocardiography-from technical considerations to clinical applications. J Am Soc Echocardiogr 2007, 20:234-243.
19. Wu C., Li T., Savai K., Griffith B., Wu Z. Strain mapping of LV myocardium and its correlation with activation of apoptotic molecular pathways post infarction. Proceedings of ASME Summer Bioengineering Conference 2008, Marco Island, FL, USA June 25-29, 2008, B.B. Lieber, D.A. Vorp, R.E. Debski, O. Akkus (Eds.).
20. Holmes J.W., Yamashita H., Waldman L.K., Covell J.W. Scar remodeling and transmural deformation after infarction in the pig. Circulation 1994, 90:411-420.
21. Li T., Kilic A., Wei X., Wu C., Schwartzbauer G., Yankey G.K., et al. Regional imbalanced activation of the calcineurin/BAD apoptotic pathway and the PI3K/Akt survival pathway after myocardial infarction. Int J Cardiol 2013, 166:158-165.
22. Wang Z., Petersen K., Weaver M.S., Magnuson N.S. cDNA cloning, sequencing and characterization of bovine pim-1. Vet Immunol Immunopathol 2001, 78:177-195.
23. Abbate A., Biondi-Zoccai G.G., Bussani R., Dobrina A., Camilot D., Feroce F., et al. Increased myocardial apoptosis in patients with unfavorable left ventricular remodeling and early symptomatic post-infarction heart failure. J Am Coll Cardiol 2003, 41:753-760.
24. Baldi A., Abbate A., Bussani R., Patti G., Melfi R., Angelini A., et al. Apoptosis and post-infarction left ventricular remodeling. J Mol Cell Cardiol 2002, 34:165-174.
25. Reeves R., Spies G.A., Kiefer M., Barr P.J., Power M. Primary structure of the putative human oncogene, pim-1. Gene 1990, 90:303-307.
26. Khaleghpour K., Pyronnet S., Gingras A.C., Sonenberg N. Translational homeostasis: eukaryotic translation initiation factor 4E control of 4E-binding protein 1 and p70 S6 kinase activities. Mol Cell Biol 1999, 19:4302-4310.
27. Shay K.P., Wang Z., Xing P.X., McKenzie I.F., Magnuson N.S. Pim-1 kinase stability is regulated by heat shock proteins and the ubiquitin-proteasome pathway. Mol Cancer Res 2005, 3:170-181.
28. Hu X.F., Li J., Vandervalk S., Wang Z., Magnuson N.S., Xing P.X. PIM-1-specific mAb suppresses human and mouse tumor growth by decreasing PIM-1 levels, reducing Akt phosphorylation, and activating apoptosis. J Clin Invest 2009, 119:362-375.
29. Ionov Y., Le X., Tunquist B.J., Sweetenham J., Sachs T., Ryder J., et al. Pim-1 protein kinase is nuclear in Burkitt's lymphoma: nuclear localization is necessary for its biologic effects. Anticancer Res 2003, 23:167-178.
30. Xie Y., Xu K., Linn D.E., Yang X., Guo Z., Shimelis H., et al. The 44-kDa Pim-1 kinase phosphorylates BCRP/ABCG2 and thereby promotes its multimerization and drug-resistant activity in human prostate cancer cells. J Biol Chem 2008, 283:3349-3356.
31. Telerman A., Amson R., Zakut-Houri R., Givol D. Identification of the human pim-1 gene product as a 33-kilodalton cytoplasmic protein with tyrosine kinase activity. Mol Cell Biol 1988, 8:1498-1503.
32. Weinberg R.A. The action of oncogenes in the cytoplasm and nucleus. Science 1985, 230:770-776.
33. Chiang C.W., Kanies C., Kim K.W., Fang W.B., Parkhurst C., Xie M., et al. Protein phosphatase 2A dephosphorylation of phosphoserine 112 plays the gatekeeper role for BAD-mediated apoptosis. Mol Cell Biol 2003, 23:6350-6362.
34. Katsumi A., Orr A.W., Tzima E., Schwartz M.A. Integrins in mechanotransduction. J Biol Chem 2004, 279:12001-12004.
35. Tu M.L., Wang H.Q., Sun X.D., Chen L.J., Peng X.C., Yuan Y.H., et al. Pim-1 is up-regulated by shear stress and is involved in shear stress-induced proliferation of rat mesenchymal stem cells. Life Sci 2011, 88:233-238.
36. Katare R., Caporali A., Zentilin L., Avolio E., Sala-Newby G., Oikawa A., et al. Intravenous gene therapy with PIM-1 via a cardiotropic viral vector halts the progression of diabetic cardiomyopathy through promotion of prosurvival signaling. Circ Res 2011, 108:1238-1251.
37. Larkin M.A., Blackshields G., Brown N.P., Chenna R., McGettigan P.A., McWilliam H., et al. Clustal W and Clustal X version 2.0. Bioinformatics 2007, 23:2947-2948.